Leadership Overview
Rohto has 6 executives leading key functions including strategy, financial oversight, operational management, technical innovation, corporate governance, and regional market expansion.
Committed to health and wellness, Rohto advances global pharmaceutical and cosmetic standards through rigorous research and consumer-focused product development.
Committed to health and wellness, Rohto advances global pharmaceutical and cosmetic standards through rigorous research and consumer-focused product development.
Leadership Roles at Rohto
Nobuhiro Hirasawa - Chief Executive Officer
Nobuhiro Hirasawa, the Chief Executive Officer at Rohto, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the global pharmaceutical and cosmetic portfolio, the Chief Executive Officer ensures alignment between research initiatives and market demands. This leadership role involves managing complex international operations while maintaining the high quality standards established since 1899. By fostering innovation across the product development pipeline, Nobuhiro Hirasawa directly impacts the competitive positioning of the company within the global health sector. The Chief Executive Officer coordinates with the board to drive sustainable growth and operational excellence. Through strategic resource allocation, the Chief Executive Officer secures the future trajectory of the firm. Hirasawa maintains a focus on expanding the reach of pharmaceutical and food products into emerging markets, ensuring that the company remains a leader in the wellness industry while delivering consistent value to stakeholders worldwide.
Masaya Saito - Executive Vice President & Chief Financial Officer
Masaya Saito, the Executive Vice President & Chief Financial Officer at Rohto, manages the fiscal health and capital allocation strategies of the enterprise. Overseeing financial reporting, risk management, and investment planning, the Executive Vice President & Chief Financial Officer ensures the stability of the balance sheet. This leadership role involves optimizing the cost structure across manufacturing and marketing divisions to support long-term profitability. By implementing rigorous financial controls, Masaya Saito directly impacts the efficiency of the global supply chain and research investments. The Executive Vice President & Chief Financial Officer collaborates with other senior leaders to evaluate potential acquisitions and market expansions. Through precise financial forecasting, the Executive Vice President & Chief Financial Officer provides the necessary data to guide corporate decision-making. Saito maintains a focus on maximizing shareholder returns while supporting the ongoing development of innovative cosmetic and pharmaceutical solutions across diverse international markets.
Masashi Sugimoto - President & Chief Operating Officer
Masashi Sugimoto, the President & Chief Operating Officer at Rohto, executes the daily operational strategies and manufacturing workflows across all business units. Overseeing the production of pharmaceutical, cosmetic, and food products, the President & Chief Operating Officer ensures that quality standards remain consistent with the company legacy. This leadership role involves streamlining internal processes to improve output efficiency and responsiveness to consumer needs. By managing the integration of new technologies into the manufacturing cycle, Masashi Sugimoto directly impacts the scalability of the product portfolio. The President & Chief Operating Officer coordinates with regional managers to ensure that operational goals align with the broader corporate mission. Through the optimization of logistics and resource management, the President & Chief Operating Officer maintains a high level of operational agility. Sugimoto focuses on driving continuous improvement in production methodologies to support the expansion of the brand into new global territories.

Hidetoshi Segi - President & Representative & Director
Hidetoshi Segi, the President & Representative & Director at Rohto, governs the corporate structure and ensures compliance with regulatory standards across all jurisdictions. Overseeing the board interactions and representative duties, the President & Representative & Director maintains the integrity of the corporate governance framework. This leadership role involves representing the company in high-level negotiations and ensuring that all business activities adhere to the core mission of health and wellness. By fostering strong relationships with stakeholders and regulatory bodies, Hidetoshi Segi directly impacts the reputation and legal standing of the organization. The President & Representative & Director coordinates with the executive team to ensure that strategic initiatives remain consistent with the long-term interests of the company. Through the oversight of corporate policies, the President & Representative & Director secures the ethical foundation of the business. Segi focuses on maintaining the trust of consumers and partners while guiding the firm through complex regulatory landscapes.
Takashi Koga - President of Rohto Brasil Holding E Prticipacoes
Takashi Koga, the President of Rohto Brasil Holding E Prticipacoes at Rohto, drives the strategic expansion and market penetration within the South American region. Overseeing the local operations and business development initiatives, the President of Rohto Brasil Holding E Prticipacoes ensures that the brand effectively reaches diverse consumer segments. This leadership role involves adapting the global product portfolio to meet the specific needs and regulatory requirements of the Brazilian market. By managing local partnerships and distribution networks, Takashi Koga directly impacts the growth trajectory of the company in the region. The President of Rohto Brasil Holding E Prticipacoes coordinates with the global headquarters to align regional performance with international objectives. Through the implementation of localized marketing and sales strategies, the President of Rohto Brasil Holding E Prticipacoes strengthens the presence of the company in the competitive pharmaceutical and cosmetic landscape. Koga focuses on building a sustainable and profitable footprint across the South American market.
Shinichi Kunisaki - Executive Vice President & Chief Technical Officer & Chief Technology Officer
Shinichi Kunisaki, the Executive Vice President & Chief Technical Officer & Chief Technology Officer at Rohto, architects the research and development framework for all pharmaceutical and cosmetic innovations. Overseeing the laboratory teams and technical infrastructure, the Executive Vice President & Chief Technical Officer & Chief Technology Officer ensures that scientific advancements translate into viable consumer products. This leadership role involves bridging the gap between cutting-edge research and large-scale manufacturing requirements. By directing the technical roadmap, Shinichi Kunisaki directly impacts the ability of the company to maintain a competitive edge in the health and wellness market. The Executive Vice President & Chief Technical Officer & Chief Technology Officer collaborates with external research partners to foster breakthrough discoveries. Through the implementation of advanced technology systems, the Executive Vice President & Chief Technical Officer & Chief Technology Officer enhances the precision and safety of the product line. Kunisaki drives the technical evolution of the firm to meet modern health challenges.

Explore Leadership Teams in Manufacturing
Founded in 2005, Headquartered in Tokyo, Daiichi Sankyo is a global pharmaceutical company that develops and provides innovative new and generic medicines, as well as advanced drug discovery and delivery methods, serving patients in over 30 countries.
Company Leadership
KM
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.
Company Leadership RM
PT
DS
JB
Daiichi Sankyo is a global healthcare company dedicated to transforming lives through scientific innovation and technology, with a strong focus on oncology. The company develops and commercializes a leading portfolio of antibody drug conjugates (ADCs) and other innovative therapies to address diverse medical needs. Its primary clients include healthcare professionals and patients, as it aims to deliver practice-changing medicines that enhance quality of life. With a commitment to research and development, Daiichi Sankyo strives to advance new standards of care in the healthcare industry.
Company Leadership DM
SK
EM
AY
Ascend Wellness Holdings is an American cannabis company specializing in the cultivation, processing, manufacturing, distribution, and retail sale of cannabis products. The company operates as a vertically integrated multi-state operator, managing different stages of the cannabis supply chain through cultivation facilities, manufacturing operations, branded product development, wholesale distribution, and retail dispensaries. Its business is focused on serving adult-use and medical cannabis markets in states where cannabis sales are permitted under applicable state regulations. The company aims to provide consumers with a consistent selection of cannabis products through its integrated production and retail network.
Company Leadership SB


MM